OBJECTIVE: To assess the noninferiority of a task-shifting HIV treatment model relying on peer counselors and nurses compared with a physician-centered model among HIV-1-positive women initiated on antiretroviral therapy (ART) at a prevention of mother-to-child transmission clinic in Mulago Hospital, Uganda. METHODS:HIV-1-infected ART eligible naive women were randomized to either nurse-peer (intervention) or doctor-counselor (standard model) arm. The primary endpoint was virologic success defined attaining a viral load < 400 RNA copies per milliliter 6-12 months after ART initiation. Noninferiority was defined as the lower 95% confidence limit for the difference in proportions with virologic success being less than 10%. Secondary outcomes included immunologic success (mean CD4 count increase from baseline) and pill count. RESULTS: Data on 85 participants were analyzed (n = 45 in the intervention and n = 40 in the standard model). The proportion of participants with virologic success was similar in the standard and intervention models [91% versus 88% respectively; difference, 3%; 95% confidence interval (CI): -11% to 12%]. Probability of viral detection at 6-12 months' time point was similar in the 2 models (log-rank test P = 0.73). Immunologic and pill count indicators were also similar in the intervention and standard models, with mean CD4 increase of 217 versus 206 cells per microliter (difference, 11; 95% CI: -60 to 82 cells/μL) and pill counts of 99.8% versus 99.7% (difference, 0.0; 95% CI: -5% to 5%) respectively. CONCLUSIONS: Nurses and peer counselors were not inferior in providing ART follow-up care to postpartum women, an approach that may help deliver treatment to many more HIV-infected people.
RCT Entities:
OBJECTIVE: To assess the noninferiority of a task-shifting HIV treatment model relying on peer counselors and nurses compared with a physician-centered model among HIV-1-positive women initiated on antiretroviral therapy (ART) at a prevention of mother-to-child transmission clinic in Mulago Hospital, Uganda. METHODS:HIV-1-infectedART eligible naive women were randomized to either nurse-peer (intervention) or doctor-counselor (standard model) arm. The primary endpoint was virologic success defined attaining a viral load < 400 RNA copies per milliliter 6-12 months after ART initiation. Noninferiority was defined as the lower 95% confidence limit for the difference in proportions with virologic success being less than 10%. Secondary outcomes included immunologic success (mean CD4 count increase from baseline) and pill count. RESULTS: Data on 85 participants were analyzed (n = 45 in the intervention and n = 40 in the standard model). The proportion of participants with virologic success was similar in the standard and intervention models [91% versus 88% respectively; difference, 3%; 95% confidence interval (CI): -11% to 12%]. Probability of viral detection at 6-12 months' time point was similar in the 2 models (log-rank test P = 0.73). Immunologic and pill count indicators were also similar in the intervention and standard models, with mean CD4 increase of 217 versus 206 cells per microliter (difference, 11; 95% CI: -60 to 82 cells/μL) and pill counts of 99.8% versus 99.7% (difference, 0.0; 95% CI: -5% to 5%) respectively. CONCLUSIONS: Nurses and peer counselors were not inferior in providing ART follow-up care to postpartum women, an approach that may help deliver treatment to many more HIV-infected people.
Authors: Jennifer A Pellowski; Devon M Price; Abigail D Harrison; Emily L Tuthill; Landon Myer; Don Operario; Mark N Lurie Journal: AIDS Behav Date: 2019-08
Authors: Michelle Dynes; Laura Tison; Carla Johnson; Andre Verani; Alexandra Zuber; Patricia L Riley Journal: J Assoc Nurses AIDS Care Date: 2015-11-18 Impact factor: 1.354
Authors: Edward J Mills; Richard Lester; Kristian Thorlund; Maria Lorenzi; Katherine Muldoon; Steve Kanters; Sebastian Linnemayr; Robert Gross; Yvette Calderon; K Rivet Amico; Harsha Thirumurthy; Cynthia Pearson; Robert H Remien; Lawrence Mbuagbaw; Lehana Thabane; Michael H Chung; Ira B Wilson; Albert Liu; Olalekan A Uthman; Jane Simoni; David Bangsberg; Sanni Yaya; Till Bärnighausen; Nathan Ford; Jean B Nachega Journal: Lancet HIV Date: 2014-11-24 Impact factor: 12.767
Authors: Becky L Genberg; Sylvia Shangani; Kelly Sabatino; Beth Rachlis; Juddy Wachira; Paula Braitstein; Don Operario Journal: AIDS Behav Date: 2016-10
Authors: Jean B Nachega; Olatunji Adetokunboh; Olalekan A Uthman; Amy W Knowlton; Frederick L Altice; Mauro Schechter; Omar Galárraga; Elvin Geng; Karl Peltzer; Larry W Chang; Gilles Van Cutsem; Shabbar S Jaffar; Nathan Ford; Claude A Mellins; Robert H Remien; Edward J Mills Journal: Curr HIV/AIDS Rep Date: 2016-10 Impact factor: 5.071
Authors: Sharon Tsui; Caitlin E Kennedy; Lawrence H Moulton; Larry W Chang; Jason E Farley; Kwasi Torpey; Eric van Praag; Olivier Koole; Nathan Ford; Fred Wabwire-Mangen; Julie A Denison Journal: Trop Med Int Health Date: 2021-08-08 Impact factor: 2.622